The $125m venture financing of BillionToOne was the medical devices industry’s top cross border venture financing deal as total deals worth $712m were announced globally in March 2022, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 41.6% over the previous month of $1.22bn and a drop of 42.6% when compared with the last 12-month average, which stood at $1.24bn.
Comparing cross border venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $586m. At the country level, the US topped the list in terms of deal value at $563.5m.
In terms of volumes, North America emerged as the top region for medical devices industry cross border venture financing deals globally, followed by Europe and then Asia-Pacific.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The top country in terms of cross border venture financing deals activity in March 2022 was the US with 21 deals, followed by the Canada with three and France with two.
In 2022, as of March, medical devices cross border venture financing deals worth $2.86bn were announced globally, marking an increase of 25.1% year on year.
medical devices industry cross border venture financing deals in March 2022: Top deals
The top five medical devices industry cross border venture financing deals accounted for 58.7% of the overall value during March 2022.
The combined value of the top five medical devices cross border venture financing deals stood at $418m, against the overall value of $712m recorded for the month.
The top five medical devices industry cross border venture financing deals of March 2022 tracked by GlobalData were:
1) Adams Street Partners,Baillie Gifford,Civilization Ventures,Fifty Years Fund,Hummingbird Ventures,Libertus Capital,NeoTribe Ventures,Norwest Venture Partners,Pacific 8 Ventures and Time BioVentures $125m venture financing deal with BillionToOne
2) The $100m venture financing of Visby Medical by Artiman Ventures,Blue Water Life Science Advisors,Cedars-Sinai Medical Center,Healthcare of Ontario Pension Plan,John Doerr,ND Capital,Nissim Capital,Ping An Voyager Partners and Pitango Venture Capital
3) Ally Bridge Group,Ascension Health Ventures,Catalio Capital Management,Hillenbrand Capital,Johnson & Johnson Innovation – JJDC,KCK Group,Pfizer Venture Investments,PSP INVESTMENTS,Sixty Degree Capital,T Rowe Price Associates,The Rise Fund and Venrock Healthcare Capital Partners $80m venture financing deal with RefleXion Medical
4) The $73m venture financing of Deepcell by Andreessen Horowitz,Bow Capital,Bridger Healthcare Partners,Casdin Capital,Horizons Ventures,Jeff Dean,Koch Disruptive Technologies and Matthew McIlwain
5) HealthQuad,Mass Mutual Ventures and Novo Holdings $40m venture financing deal with Qure.ai Technologies